Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. (SBRT/IL-2)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Providence Health & Services
Sponsor:
Collaborator:
Prometheus Laboratories
Information provided by (Responsible Party):
Providence Health & Services
ClinicalTrials.gov Identifier:
NCT01416831
First received: August 12, 2011
Last updated: June 23, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2018
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)